Skip to content

Spain logo

Main menu
    • Sobre nosotros
      • Vision, mision y valores
      • Diversidad, igualdad e inclusión
    • Principios ambientales, sociales y de buen gobierno
    • Nuestras políticas y posicionamientos
    • Proveedores
  • Nuestros productos
  • Salud con Perspectiva
  • Sala de prensa
  • Únete a nuestro equipo
  • Profesionales sanitarios

Contacta con nosotros

Lista de productos

Visit Organon's Twitter Opens a new window Visit Organon's LinkedIn Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Sala de prensa

Nuestras últimas noticias

Notas de prensa

La información contenida en cada nota de prensa publicada en esta página corresponde a la fecha en que se publicó. Organon no asume la obligación de actualizar la información para reflejar desarrollos posteriores. Al leer las notas de prensa, no se debe asumir que la información sea actual o precisa después de las fechas de publicación.

July 16, 2025

Nace Carmen, alianza pionera de empresas, universidades y fundaciones que trabajarán de forma coordinada para la reducción de las desigualdades en la salud de las mujeres

June 4, 2025

El secretario de Estado de Sanidad, Javier Padilla, participa en el pódcast ‘Salud con perspectiva’ para abordar la salud integral de las mujeres

May 28, 2025

El 75% de las mujeres acude sola al médico, a pesar de ser las principales cuidadoras a nivel familiar

View all

Contacta con Comunicación

Para las preguntas de los medios, por favor contactar con el departamento de Comunicación a través de:

+34 91 591 1279

comunicacion.espana@organon.com

Recursos para los medios

Recursos destinados al uso de los profesionales de los medios de comunicación.

Estas imágenes se pueden descargar para uso no comercial y con fines tales como informes de noticias o investigación. Las imágenes no pueden modificarse y deben mostrar el siguiente copyright: Copyright © Grupo de empresas Organon. Reservados todos los derechos.

Organon logo
Descargar
Organon Here for her health logo
Descargar
Organon Aquí por la Salud de la Mujer
Descargar
Organon Here for Her Health (English Subtitled) 
Descargar
Organon Through Her Eyes (subtitulado en español)
Descargar

Conecta con nosotros

Linkedin icon Opens a new window Twitter icon Opens a new window
Spain logo
  • Política de privacidad
  • Derechos sobre datos personales
  • Términos y condiciones de uso
  • Canal de denuncias
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept